Zhou S, Lv H, Li A, Li M, et al. A clinicopathological study and survival analysis of 99 breast cancers with HER2/CEP17 ratio >/= 2.0 and an average HER2 copy number < 4.0 per cell in China. BMC Cancer 2023;23:84.
PMID: 36698078